in-lin quarter updat organ growth guidanc remain
sidelin cl success year acceler organ growth
stock run ytd vs believ
improv alreadi factor current valuat look back
half year interest see china trend improv
chang macro latam maintain price target
equat ep in-lin peer maintain hold
rais estim slightli
maintain ep estim note estim
includ contribut pend filorga privat acquisit
expect close
pleas see attach document full recap updat model
tr target
recap follow note publish morn link recal cl report
earn believ view rel line net sale
yoy estim yoy consensu estim
yoy organ sale growth high end compani organ growth
guidanc rang adjust ep estim in-lin
consensu estim compani maintain outlook adjust ep declin
mid-single-digit equat ep expect organ sale growth toward
higher end guidanc rang
takeaway confer call key takeaway morn confer call
list
china expect improv back half china quarter drag
overal sale result apac origin began cl took price year ago
chines distribut channel significantli fragment us sheer
number distributor draw inventori balanc prior reorder higher
price greater impact cl right size inventori balanc said
expect improv china back half year opinion import
cl begin post growth chines market back half year
main drag otherwis strong apac region region strong
grower busi go forward opinion hope trend begin
filorga cl gave littl detail call filorga recal compani
announc agre acquir filorga deal expect
close link note today gave addit guidanc includ
filorga sale year end june growth margin profil
busi nice accret cl acquisit expect net neutral
ep accret ep compani note slow share
repurchas activ year post deal close help pay debt sooner said
origin note believ good acquisit give cl exposur
categori skin care grow well compani note global categori grow
accret margin profil
maintain hold compani post better organ result far year believ
good news alreadi reflect valuat look forward interest see china
return growth back half year four quarter declin due inventori
chang market posit side total relaunch nice benefit price hill
busi scienc diet relaunch fire post back back quarter
organ growth said arent readi chase stock level would look
page
dollar million except per-shar data
good sold
compani report suntrust robinson humphrey estim
price
page
colgate-palmol lead global consum product compani special oral
pet nutrit compani market product retail wholesal
custom distributor veterinarian specialti pet retail north america latin america
europ asia africa addit colgat palmol product line compani brand
portfolio also includ softsoap irish spring mennen fab ajax scienc diet
hold rate base belief cl emerg market busi continu struggl
macro volatil weigh busi fx remain headwind dollar strengthen
believ best remain sidelin compani show sign current strategi
driven primarili increas market spend wait emerg market improv make
valuat risk
price target base price-to-earnings multipl ep estim in-lin peer group
averag downsid risk rate price target includ global macroeconom
uncertainti sector rotat consum stapl higher commod cost inventori
destock larg custom upsid risk includ improv emerg market weaker
dollar upsid marketing/new innov
compani mention note
william chappel jr herebi certifi view express research report accur
reflect person view subject compani secur also certifi
receiv direct indirect compens exchang
express specif recommend report
